Hematology Drugs Global Market Report 2018

Starting Price : $ 4000.00 | Pages : 125 | Published : February 2018 | SKU CODE : 3254 | Format :

Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, and conditions related to sickle cell disease and other related diseases. Some of the major hematology drugs include Albumin, Epoetin, Zoladex, and Hyskon.

The top five companies covered are Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited and Biogen Inc. Novo Nordisk was the largest company in the hematology drug market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The global hematology drugs market was valued at above $39 billion in 2017. North America was the largest region in the hematology drugs market in 2017, accounting for around 40% market share. The USA was the largest country in the market in 2017, accounting for 32% market share.

Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its cheap price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage. In April 2017, WOMAN (World Maternal Antifibrinolytic), an international, randomized, double-blind, placebo-controlled trial including over 20,000 women from 193 hospitals in 21 countries, found that using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%, as compared to placebo.

The hematology drugs market is segmented into Blood Products and Anemia And Other Blood Disorder Drugs. Blood Products segment includes companies that produce blood components such as red cells, platelets, fresh frozen plasma and cryoprecipitate, or plasma derivatives such as albumin and immunoglobulin. Anemia And Other Blood Disorder Drugs segment includes companies that produce drugs that can be used to prevent and treat anemia and bleeding disorders such as hemophilia and blood clots.

Next-gen Biologics- The Way Forward

The Telemedicine Technology Market Will More Than Double by 2022

Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion

Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say

Organs-on-Chips to Revolutionize the Drug Development Industry

Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe

The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America

Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC

Blood Glucose Test Strips Global Market Report 2018

View Report

Veterinary Services Global Market Report 2018

View Report

Podiatry Services Global Market Strategies and Opportunities to 2021

View Report

Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021

View Report

Biologics Global Market Opportunities And Strategies To 2021

View Report

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021

View Report

Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021

View Report

Veterinary Serices Global Market Opportunities And Strategies To 2021

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)